LUMO Message Board Post 10985190 | Lumos Pharma Inc.
home / stock / lumo / lumo message board
(investorshangout)
Posted on: Dec/20/2019 15:30:42
Source: investorshangout
https://investorshangout.com/post/view?id=5624628
whytestocks: $NLNK News Article - NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO )
News, Short Squeeze, Breakout and More Instantly...
-
AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today details of new analyses of data from its Phase 2 OraGrowtH212 clinical trial presented in two posters at the...
-
AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new analyses of data from its Phase 2 OraGrowtH210 and OraGrowtH212 clinical trials have been accepted f...
-
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201 Achieves Significant Increase in Growth from Baseline, Durable Effect to 24 Months ...